Barclays’s Ambev ABEV Stock Holding History

Barclays’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-13,500	Closed	-$81K	–	7044
2014 Q4	$81K	Sell	13,500 -3,000	-18%	-$18.9K	﹤0.01%	5360
2014 Q3	$99K	Hold	16,500	–	–	﹤0.01%	5338
2014 Q2	$116K	Hold	16,500	–	–	﹤0.01%	5304
2014 Q1	$116K	Sell	16,500 -39,000	-70%	-$273K	﹤0.01%	5308
2013 Q4	$389K	Buy	+55,500	New	+$406K	﹤0.01%	4346

Other funds holding ABEV

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Barclays's ABEV Position: Q2 2026 in Review

Barclays increased its Ambev (ABEV) stake by 24,038% in Q2 2026, buying an estimated $513K and bringing the position to 164,622 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.

Barclays first reported a position in ABEV in Q4 2013 and has held it in 43 quarters since. The position peaked at $12.9M in Q3 2015. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

Barclays held 164,622 shares of Ambev worth $517K as of Q2 2026.
Barclays bought 163,940 Ambev shares in Q2 2026, an estimated $513K.
Ambev made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3204 holding.
Barclays first reported a position in Ambev in Q4 2013 and has held it in 43 quarters since.
Barclays's Ambev position peaked at $12.9M in Q3 2015.
404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.